Janux Therapeutics Inc

NASDAQ JANX

Data sourced from iex and EODHD
Download Data

Janux Therapeutics Inc Key Metrics 2019 - 2023

This table shows the Key Metrics for Janux Therapeutics Inc going from 2019 until 2023. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Accounts Payable Turnover Ratio
R 3.33 3.99 1.48 0.89 0.00
Accounts Receivable Turnover Ratio
R 3.67 12.30 18.19 0.05 -
Asset Coverage Ratio
R - - - - -
Asset Turnover Ratio
R 0.04 0.05 0.02 0.05 -
Average Collection Period
R 167.37 129.75 113.10 3,961.69 -
Book Value Per Share
R 7.82 7.73 8.88 -0.35 -1.24
Capital Expenditure To Sales
% 22.89 74.84 40.75 390.00 -
Cash Dividend Coverage Ratio
R - - - - -
Cash Flow Coverage Ratio
R - -12.24 -49.89 -28.40 -22.79
Cash Interest Coverage Ratio
R - -10.65 -45.88 -21.21 -16.43
Cash Per Share
R 0.44 1.24 0.86 0.19 0.10
Cash Ratio
R 1.47 3.12 2.78 2.46 0.14
Cash Return on Assets (CROA)
R -0.13 -0.12 -0.04 -0.27 -5.64
Cash Return on Equity (CROE)
R -0.15 -0.13 -0.05 0.30 0.48
Cash Return on Invested Capital (CROIC)
R -0.14 -0.12 -0.05 -0.34 0.97
Cash Return on Investment (CROI)
R - - - - -
Cash Taxes
M - -11 0 0 0
Cash to Debt Ratio
R - - - - -
Current Assets to Total Assets Ratio
R 0.92 0.91 0.99 0.99 0.97
Current Liabilities Ratio
R 0.03 0.05 0.03 0.20 6.81
Current Liabilities to Total Liabilities Ratio
R 0.36 0.38 0.95 0.10 0.54
Current Ratio
R 26.80 20.14 29.46 5.05 0.14
Days in Inventory
R 281.26 11.39 9.25 - -
Days Inventory Outstanding (DIO)
R -410.74 -3.38 -2.00 - -
Days Payable Outstanding (DPO)
R 452.56 10.41 24.54 12,016.92 -
Days Sales Outstanding (DSO)
R 99.34 29.67 20.07 7,684.21 -
Debt to Asset Ratio
R - - - - -
Debt to Capital Ratio
R - - - - -
Debt to EBITDA Ratio
R - - - - -
Debt to Equity Ratio
R - - - - -
Debt to Income Ratio
R - - - - -
Debt to Tangible Net Worth Ratio
R - - - - -
Dividend Coverage Ratio
R - - - - -
Dividend Payout Ratio
% - - - - -
Dividend Per Share
R - - - - -
EBIT to Fixed Assets Ratio
R -2.62 -2.28 -20.62 -31.25 -179.57
EBIT to Total Assets Ratio
R -0.19 -0.18 -0.09 -0.30 -5.55
EBITDA Coverage Ratio
R - -16.43 -88.69 -31.87 -16.16
EBITDA Per Share
R -1.61 -1.60 -0.80 -0.16 -0.59
Equity Multiplier
R 1.10 1.13 1.04 -1.11 -0.09
Equity to Assets Ratio
R 0.91 0.88 0.96 -0.90 -11.70
Free Cash Flow Margin
R -6.49 -5.73 -5.08 -11.50 -
Free Cash Flow Per Share
R -1.19 -1.19 -0.45 -0.10 -0.60
Free Cash Flow to Equity (FCFE)
M - - - - -
Free Cash Flow to Firm (FCFF)
M - -46 -18 -4 -4
Gross Profit Per Share
R 0.14 0.21 0.09 0.00 -
Gross Profit to Fixed Assets Ratio
R 0.22 0.29 2.28 -0.08 -
Gross Profit to Tangible Assets Ratio
R - - - - -
Gross Working Capital
M 335 315 364 12 -8
Interest Coverage Ratio
R - -16.64 -89.00 -23.51 -16.18
Interest Expense To Sales
% - 46.82 10.17 54.21 -
Inventory Turnover Ratio
R -0.89 -108.15 -182.83 - -
Invested Capital
M 369 348 367 14 0
Liabilities to Equity Ratio
R 0.10 0.13 0.04 -2.11 -1.09
Long-Term Debt to Equity Ratio
R - - - - -
Long-Term Debt to Total Assets Ratio
R - - - - -
Net Current Asset Value
R 313,183,000.00 289,169,000.00 363,522,000.00 -14,793,000.00 -7,965,000.00
Net Debt to EBITDA Ratio
R -0.08 0.39 1.08 1.19 -0.89
Net Income Before Taxes
R - -63,059,000.00 -32,672,000.00 -6,784,000.00 -4,004,000.00
Net Operating Profit After Tax (NOPAT)
R - -56,894,376.69 -32,702,501.96 -5,085,358.93 -3,984,092.16
Net Working Capital to Total Assets Ratio
R 0.88 0.87 0.96 0.79 -5.85
Non-current Assets to Total Assets Ratio
R 0.08 0.09 0.01 0.01 0.03
Non-current Liabilities to Total Liabilities Ratio
R 0.64 0.62 0.05 0.90 0.46
Operating Cash Flow Per Share
R -1.15 -1.04 -0.41 -0.10 -0.60
Operating Cash Flow To Current Liabilities
R -3.88 -2.60 -1.33 -1.37 -0.83
Operating Cash Flow to Debt Ratio
R - - - - -
Operating Cash Flow to Sales Ratio
% -625.70 -498.40 -466.76 -1,149.74 -
Operating Expense Ratio
% 978.68 879.04 1,005.39 1,271.05 -
Operating Income Per Share
R -1.66 -1.62 -0.80 -0.12 -0.59
Operating Income to Total Debt
R - - - - -
Payables Turnover
R 0.81 35.06 14.88 0.03 -
Pre-Tax Margin
% -902.87 -779.04 -905.39 -1,274.47 -
Quick Ratio
R 26.97 20.18 29.48 - -
Research and Development (R&D) Expense Ratio
% 679.48 620.54 721.39 800.26 -
Retained Earnings To Equity Ratio
R -0.49 -0.34 -0.13 1.01 1.00
Retention Ratio
% - - - - -
Return on Assets (ROA)
% -15.32 -14.88 -8.57 -32.40 -624.01
Return on Capital Employed (ROCE)
% -19.87 -19.31 -8.97 -37.15 95.52
Return on Common Equity
% - -128,938.10 -79,412.20 -525,500.00 -423,700.00
Return on Equity (ROE)
% -16.93 -16.88 -8.89 35.90 53.34
Return on Fixed Assets (ROFA)
% -209.38 -184.42 -2,038.76 -3,390.32 -20,176.19
Return on Gross Investment (ROGI)
% - - - - -
Return on Investment (ROI)
% - - - - -
Return on Net Assets (RONA)
% -8.13 -7.96 -4.38 -18.06 128.78
Return on Net Investment (RONI)
% - - - - -
Return on Sales (ROS)
% -721.18 -628.82 -895.22 -1,382.89 -
Return on Tangible Equity (ROTE)
% - - - - -
Return on Total Capital (ROTC)
% - - - - -
Revenue Per Share
M 0 0 0 0 0
Sales to Fixed Assets Ratio
R 0.29 0.29 2.28 2.45 0.00
Sales to Operating Cash Flow Ratio
R -0.16 -0.20 -0.21 -0.09 0.00
Sales to Total Assets Ratio
R 0.02 0.02 0.01 0.02 0.00
Sales to Working Capital Ratio
R 0.02 0.03 0.01 0.03 0.00
Selling, General, and Administrative (SG&A) Expense Ratio
% 323.39 258.50 284.00 474.21 -
Short-Term Debt to Equity Ratio
R 0.00 0.00 0.00 -0.05 -0.50
Short-Term Debt to Total Assets Ratio
R 0.00 0.00 0.00 0.05 5.89
Tangible Asset Value Ratio
R - 0.88 0.96 -0.90 -11.70
Tangible Book Value per Share
R - - - - -
Total Debt to Capital Ratio
R - - - - -
Total Liabilities to Total Assets Ratio
R 0.09 0.12 0.04 1.90 12.70
Working Capital to Current Liabilities Ratio
R 25.80 19.14 28.46 4.05 -0.86
Working Capital To Sales Ratio
R 41.59 36.69 100.14 33.90 -
Working Capital Turnover Ratio
R 0.02 0.03 0.01 0.03 0.00

StockViz Staff

September 19, 2024

Any question? Send us an email